A new Jefferson County Public Health program looks to help young people who use nicotine through low-cost or free nicotine ...

Dr Reddy’s kicks off India’s big pharma earnings season with a narrow profit miss. The pharmaceutical company reported a ...

Dr Reddy's Laboratories posted a 1% rise in net profit to Rs 1,410 crore for the June quarter, with revenue climbing to Rs 8,545 crore. Growth stemmed from branded markets and the Nicotine Replacement ...

Consumption of illicit tobacco is growing as more tobacconists pop up and revenue is lost from the legal excise.

Dr Reddy's Laboratories on Wednesday reported a 1 per cent increase in consolidated net profit to Rs 1,410 crore during the ...

Indian generic drugs maker Dr Reddy's Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it ...

Dr Reddy's Laboratories Ltd.'s consolidated net profit rose 1.8% in the first quarter of fiscal 2026, missing analysts' estimates. The pharmaceutical company posted a bottom line of Rs 1,418 crore, ...

RDY reports encouraging first-quarter fiscal 2026 results, wherein both earnings and revenues beat estimates, driven by higher global generic sales.

Dr Reddy's reported Rs 1,417 crore net profit in Q1 FY26, driven by new launches and price hikes; firm outlines global ...

Dr Reddy's Laboratories reported a 1% rise in net profit for the June quarter, with revenues increasing from Rs 7,673 crore to Rs 8,545 crore. Despite facing pricing pressures in the US generic market ...

The company's gross margin declined to 56.9 per cent, down from 60.4 per cent in the corresponding quarter of the previous ...

Pharmaceutical major Dr. Reddys Laboratories reported its financial results for the first quarter (Q1) of FY26 on Thursday, ...